ProQR to Present at the Leerink Partners 4th Annual Rare Disease Roundtable Press release LEIDEN, the Netherlands, Sept. 23, 2015 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. September 23, 2015
ProQR Announces a Proof-of-Concept Nasal Potential Difference Study of QR-010 is Open for Enrollment Press release LEIDEN, the Netherlands, Sept. 14, 2015 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (NASDAQ:PRQR) today announced that PQ-010-002 is open for enrollment. September 14, 2015
ProQR Announces Results for the Second Quarter of 2015 Press release LEIDEN, the Netherlands, Aug. 19, 2015 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. August 19, 2015
ProQR Announces Enrollment Has Started in Global Phase 1b Study of QR-010 in Cystic Fibrosis Patients Press release LEIDEN, the Netherlands, June 26, 2015 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. June 26, 2015
ProQR to Present at the JMP Securities Life Science Conference Press release LEIDEN, the Netherlands, June 16, 2015 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. June 16, 2015
ProQR Therapeutics Announces Results for the First Quarter of 2015 Press release LEIDEN, the Netherlands, May 21, 2015 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. May 21, 2015
ProQR Therapeutics Announces Annual Shareholder Meeting Press release LEIDEN, the Netherlands, April 29, 2015 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. April 29, 2015
ProQR to Present at Two Upcoming Investor Conferences in May Press release LEIDEN, the Netherlands, April 29, 2015 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. April 29, 2015
ProQR Therapeutics Announces Results for the Fourth Quarter and Full Year 2014 Press release LEIDEN, Netherlands, Feb. 26, 2015 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. February 26, 2015
ProQR to Present at the 2015 Leerink Global Healthcare Conference Press release LEIDEN, The Netherlands, Feb. 4, 2015 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. February 04, 2015